Skip to main content
Article
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation
British Journal of Haematology (2008)
  • Blaine W. Robinson, Children's Hospital of Philadelphia
  • Kathryn C. Behling
  • Manish Gupta, Children's Hospital of Philadelphia
  • Alena Y. Zhang, Children's Hospital of Philadelphia
  • Jonni S. Moore, University of Pennsylvania
  • Andrew D. Bantly, University of Pennsylvania
  • Cheryl L. Willman, University of New Mexico
  • Andrew J. Carroll, University of Alabama at Birmingham
  • Peter C. Adamson, Children's Hospital of Philadelphia
  • Jeffrey S. Barrett, Children's Hospital of Philadelphia
  • Carolyn A. Felix, University of Pennsylvania
Publication Date
January 6, 2008
DOI
10.1111/j.1365-2141.2008.07100.x
Citation Information
Blaine W. Robinson, Kathryn C. Behling, Manish Gupta, Alena Y. Zhang, et al.. "Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation" British Journal of Haematology Vol. 141 Iss. 6 (2008) p. 827 - 839
Available at: http://works.bepress.com/kathryn-behling/14/